11/03/2026
Did you know that many newborn seizures have no visible symptoms?
As part of UCC Innovation Week, we're highlighting companies emerging from the INFANT Research Centre at UCC that are translating research into technologies designed to improve children's health.
One of these spinouts is NeuroBell.
NeuroBell is developing a portable EEG monitoring device designed to help clinicians detect neonatal seizures earlier at the NICU bedside. Seizures are often the first sign of brain injury in newborns, but many have no visible symptoms.
By enabling earlier identification, NeuroBell aims to help clinicians respond more quickly and improve outcomes for newborns.
The technology was developed by researchers at the INFANT and is now moving toward clinical deployment.
The work behind NeuroBell shows how research in neonatal brain monitoring can translate into technologies that support earlier detection and care for vulnerable newborns.